The leading pharmaceutical company in Bangladesh, Incepta Pharmaceuticals Ltd. Was established in the year 1999.
TRIUMPH OF CELEBRATION
Incepta has in the past years taken numerous successful steps to be a global solution for quality healthcare products and services. Out of the 783 presentation that Incepta has, 158 were introduced for the first time in Bangladesh. Last year, 41 products were launched and out of which 11 were launched for the first time in Bangladesh.
BRAND QUOTIENT
This generic pharmaceutical company is involved with the manufacture and marketing of medicinal drugs. The company produces various types of drugs in forms of capsules, tablets, dry powder vials, oral liquids, human vaccine, nasal sprays, creams, lotions, prefilled syringes, ampoules, lyophilized injections, eye drops, ointments, etc. Incepta with its sister companies is manufacturing animal health products, hygiene products, hospital devices, biotech products, etc.
CUTTING EDGE
High investment in advanced technology and Research & Development has helped the company reach the position that it holds now. In addition to this, high quality products and the stringent quality management system of the company is what sets them apart. The “Site Validation Master Plan” is the company’s step procedure on verifying the process, system, personnel and the product.
TRAILBLAZING
In the year 2016, Incepta introduced Bangladesh’s most advanced pharmaceutical product, monoclonal antibodies named Relyto, Advixa and Denosis. These products received overwhelming feedback from the medical community. The company looks forward to develop innovative and valuable products that can improve the quality of life of people around the world. The company is also committed to maintain high focus on quality.
BRAND COMMITMENT
Incepta donates medicines and provides financial assistance for expensive treatments of cancer and heart diseases. The company also produces “import-substitute medicines” at affordable prices for the Bangladeshi people.
BRAND FACT
• Incepta exports its manufactured products in 59 countries.
MASTER STROKE
• The company also produces “import-substitute medicines” at affordable prices for the Bangladeshi people.
• Incepta donates medicines and provides financial assistance for expensive treatments of cancer and heart diseases.
INCEPTA
Brand Advertising Research & Consulting Pvt. Ltd. (BARC) is a research-based consultancy leveraging an array of services to global brands with expertise in crafting branding solutions and analysis of brand equity, marketing campaigns, market research, product development and content marketing, with a blend of innovation for growth in various industries.